Xu Chunyan, Liu Chengxia
Department of Gastroenterology and Institute of Digestive Diseases, Binzhou Medical University Hospital, Binzhou, China.
Medical Integration and practice Center, Shandong University, Jinan, China.
Transl Cancer Res. 2024 Jun 30;13(6):2596-2604. doi: 10.21037/tcr-24-98. Epub 2024 Jun 27.
Curcumin (Cur) is a natural phytochemical that is expected to become an indispensable drug for the treatment of colorectal cancer. A comprehensive understanding of the anti-tumor mechanism of Cur will provide a better reference for its clinical application. This study aimed to examine the effects of extracellular vesicles (EVs) isolated from Cur-medium on RKO colorectal cancer cell proliferation, apoptosis, and migration.
RKO cells were cultured in various concentrations of Cur-medium, and the EVs were isolated from the Cur-medium. The EVs were identified by transmission electron microscopy and western blotting. The effects of the EVs on RKO cell proliferation, apoptosis, and migration were analyzed, as was the expression of proliferating cell nuclear antigen (PCNA), Bax, vimentin, and E-cadherin. The expression of nuclear factor κB (NF-κB) p65 in the EVs was also detected.
Our results showed that the EVs isolated from the Cur-medium weakened RKO cell proliferation and migration but had no effect on cell apoptosis. Cur suppressed the expression of NF-κB p65 in the EVs. Overall, this study revealed that Cur exerts anti-tumor effects by suppressing NF-κB p65 in EVs to weaken RKO cell proliferation and migration.
In conclusion, the packaging of Cur into EVs is expected to become an indispensable treatment of colorectal cancer in the future.
姜黄素(Cur)是一种天然植物化学物质,有望成为治疗结直肠癌不可或缺的药物。全面了解Cur的抗肿瘤机制将为其临床应用提供更好的参考。本研究旨在检测从Cur培养基中分离的细胞外囊泡(EVs)对RKO结直肠癌细胞增殖、凋亡和迁移的影响。
将RKO细胞培养在不同浓度的Cur培养基中,并从Cur培养基中分离出EVs。通过透射电子显微镜和蛋白质免疫印迹法对EVs进行鉴定。分析了EVs对RKO细胞增殖、凋亡和迁移的影响,以及增殖细胞核抗原(PCNA)、Bax、波形蛋白和E-钙黏蛋白的表达。还检测了EVs中核因子κB(NF-κB)p65的表达。
我们的结果表明,从Cur培养基中分离的EVs减弱了RKO细胞的增殖和迁移,但对细胞凋亡没有影响。Cur抑制了EVs中NF-κB p65的表达。总体而言,本研究表明Cur通过抑制EVs中的NF-κB p65来减弱RKO细胞的增殖和迁移,从而发挥抗肿瘤作用。
总之,将Cur包装到EVs中有望在未来成为治疗结直肠癌不可或缺的方法。